3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
7
Polycystic Ovary Syndrome
4
Prostatic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Rectal Neoplasms
1
Psoriasis
1
Precancerous Conditions
1
Peripheral Nervous System Diseases
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Multiple Sclerosis
1
Lipid Metabolism Disorders
1
Inflammation
1
Healthy Subject
1
Dyspareunia
1
Diabetes Mellitus
1
Crohn Disease
1
Cardiovascular Diseases
1
Breast Neoplasms, Male
1
Breast Feeding
1
Breast Carcinoma In Situ
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Aggressive Periodontitis
1
Interventions
Data Collection
3
telitacicept
1
human papillomavirus vaccine, L1 type 16, 18
1
Vitamin D
1
Telemedicine
1
Plasma Exchange
1
Mycophenolic Acid
1
Immune Checkpoint Inhibitors
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CT-P13
1
Azathioprine
1
Ashwagandha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Autoimmune Diseases
×
Fish Oils
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts